A mother and daughter from Newport News, both diagnosed with colon cancer, share their story, hoping it will encourage others ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

The American Brain Tumor Association (ABTA) combines fitness, music, and medical expertise for 2nd Annual Cleveland BT5K on ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Many cancer survivors struggle with muscle weakness, which can be so profound that they may have difficulties walking up a ...

Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...